Harikanta Overseas IPO Day 7: GMP ₹0, Subscription 0.3x

Welcome back to our daily IPO updates! Today marks Day 7 of the Harikanta Overseas SME IPO subscription, and it’s been a pivotal day as the offering draws to a close. As the window for investors to participate slams shut on May 27, 2026, we’re taking a deep dive into the final subscription numbers and what they might mean for the company’s upcoming listing. The issue price is set at ₹91, and with the IPO period ending today, it’s crunch time for those still on the fence.

Subscription Status

Let’s break down the subscription figures for Harikanta Overseas as of Day 7. The overall subscription stands at a modest 0.27x. Looking at the category-wise breakdown, it’s a mixed bag. The Qualified Institutional Buyers (QIB) category has seen some traction, being subscribed 1x. This is encouraging, as QIB interest often signals confidence from institutional investors. However, the Non-Institutional Investors (NII) and Retail individual investor categories are showing 0x subscription. This is certainly something that could concern potential investors. A lack of subscription in these segments, especially retail, often suggests that the IPO hasn’t resonated strongly with the broader investor base or that the price point might be perceived as too high by many. The lot size is 1200 shares, and with no significant oversubscription in the retail or NII segments, it means most of the shares offered in these categories remain available.

GMP Update

Now, let’s talk about the Grey Market Premium (GMP). The current GMP for Harikanta Overseas is ₹0. Interestingly, this is unchanged from yesterday’s figures. A GMP of ₹0 means that the market is currently expecting the stock to list at its issue price of ₹91, with no additional premium. While a ₹0 GMP isn’t ideal, it’s also not a death knell. It simply suggests that the market sentiment isn’t currently driving significant demand above the issue price in the grey market. We saw the same yesterday, so the lack of movement indicates a stable, albeit neutral, outlook from GMP traders. This reinforces the idea that the listing might be at par, barring any last-minute surges in interest.

Should You Apply?

So, the million-dollar question: should you apply for Harikanta Overseas? Based on the data, it’s a nuanced decision. The QIB subscription is a positive sign, showing some institutional backing. However, the complete lack of subscription in the NII and retail categories is a significant red flag. Coupled with the current ₹0 GMP, it suggests that the market isn’t anticipating a strong listing gain. Investors looking for immediate returns might want to tread cautiously. On the other hand, if you believe in the long-term prospects of Harikanta Overseas and are comfortable with the issue price, applying could still be a viable option, especially with the expectation of listing at par. Remember, as per SEBI advisories, it’s always wise to conduct your own thorough research and consider your risk appetite before making any investment decisions. You can view full Harikanta Overseas IPO details here: View Full Harikanta Overseas IPO Details. The IPO period concludes today, May 27, 2026.